Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiosurgery | 3 | 2020 | 1330 | 0.480 |
Why?
|
| Professional Practice Location | 1 | 2012 | 16 | 0.440 |
Why?
|
| Professional Practice | 1 | 2012 | 82 | 0.420 |
Why?
|
| Pain | 2 | 2012 | 1658 | 0.400 |
Why?
|
| Urology | 1 | 2012 | 128 | 0.390 |
Why?
|
| Tomography, Spiral Computed | 1 | 2009 | 133 | 0.340 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2009 | 126 | 0.340 |
Why?
|
| Bone Neoplasms | 2 | 2012 | 2576 | 0.300 |
Why?
|
| Radiation Oncology | 1 | 2012 | 529 | 0.290 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 761 | 0.280 |
Why?
|
| Rectal Neoplasms | 2 | 2016 | 1202 | 0.270 |
Why?
|
| Radiotherapy, Conformal | 1 | 2009 | 902 | 0.240 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2012 | 2326 | 0.170 |
Why?
|
| Metformin | 1 | 2023 | 378 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 3022 | 0.160 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2009 | 726 | 0.150 |
Why?
|
| Acute Lung Injury | 1 | 2018 | 92 | 0.150 |
Why?
|
| Lung Injury | 1 | 2018 | 131 | 0.150 |
Why?
|
| Carcinoma, Small Cell | 1 | 2019 | 408 | 0.140 |
Why?
|
| Hospitals, Public | 1 | 2016 | 64 | 0.140 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2014 | 10 | 0.130 |
Why?
|
| Urination Disorders | 1 | 2014 | 61 | 0.120 |
Why?
|
| Urethra | 1 | 2014 | 144 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 10035 | 0.120 |
Why?
|
| Time-to-Treatment | 1 | 2016 | 292 | 0.110 |
Why?
|
| Group Practice | 1 | 2012 | 18 | 0.110 |
Why?
|
| Geographic Information Systems | 1 | 2012 | 57 | 0.110 |
Why?
|
| Ownership | 1 | 2012 | 40 | 0.100 |
Why?
|
| Time Factors | 4 | 2016 | 12926 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 1390 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 980 | 0.090 |
Why?
|
| Femur Head | 1 | 2009 | 41 | 0.090 |
Why?
|
| Body Height | 1 | 2010 | 231 | 0.090 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 1833 | 0.090 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2014 | 2231 | 0.080 |
Why?
|
| Cranial Irradiation | 1 | 2010 | 315 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 3976 | 0.080 |
Why?
|
| Pelvis | 1 | 2009 | 362 | 0.080 |
Why?
|
| Hydroxycholecalciferols | 1 | 2006 | 13 | 0.070 |
Why?
|
| Rectum | 1 | 2009 | 467 | 0.070 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2009 | 665 | 0.070 |
Why?
|
| Radiation Injuries | 1 | 2014 | 1411 | 0.070 |
Why?
|
| Urinary Bladder | 1 | 2009 | 575 | 0.070 |
Why?
|
| Receptors, Calcitriol | 1 | 2006 | 134 | 0.070 |
Why?
|
| Intestine, Small | 1 | 2009 | 499 | 0.070 |
Why?
|
| Prognosis | 3 | 2019 | 21713 | 0.070 |
Why?
|
| Texas | 2 | 2016 | 6311 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 925 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 5437 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2009 | 1529 | 0.060 |
Why?
|
| Survival Rate | 2 | 2019 | 12221 | 0.060 |
Why?
|
| Humans | 12 | 2023 | 261506 | 0.050 |
Why?
|
| Brachytherapy | 2 | 2020 | 977 | 0.050 |
Why?
|
| Chemoradiotherapy | 2 | 2020 | 1946 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2006 | 2086 | 0.040 |
Why?
|
| Drug Therapy | 1 | 2019 | 205 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 5767 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 2796 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 14889 | 0.040 |
Why?
|
| Palliative Care | 1 | 2008 | 2037 | 0.040 |
Why?
|
| General Surgery | 1 | 2019 | 326 | 0.030 |
Why?
|
| Urogenital System | 1 | 2014 | 59 | 0.030 |
Why?
|
| Prostatic Hyperplasia | 1 | 2014 | 210 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 310 | 0.030 |
Why?
|
| Cisplatin | 1 | 2020 | 2432 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 348 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2019 | 13658 | 0.030 |
Why?
|
| Neoplasms | 1 | 2018 | 15193 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 2218 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2019 | 1824 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2016 | 621 | 0.020 |
Why?
|
| Disease Management | 1 | 2016 | 1052 | 0.020 |
Why?
|
| Laser Therapy | 1 | 2014 | 411 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2023 | 37905 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 12873 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2009 | 32848 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8865 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 14289 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 70117 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 4320 | 0.010 |
Why?
|
| Adult | 2 | 2020 | 77950 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 86204 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 15694 | 0.010 |
Why?
|
| Female | 3 | 2020 | 141928 | 0.010 |
Why?
|
| United States | 1 | 2019 | 15433 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 2944 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2006 | 1392 | 0.010 |
Why?
|
| Male | 3 | 2019 | 123000 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2006 | 2084 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 21445 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 29902 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 5395 | 0.010 |
Why?
|
| Gene Expression | 1 | 2006 | 3570 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 17523 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 13310 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2010 | 16273 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 7226 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 59536 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2006 | 5178 | 0.010 |
Why?
|
| Adolescent | 1 | 2010 | 31252 | 0.010 |
Why?
|
| Child | 1 | 2010 | 29154 | 0.010 |
Why?
|